Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMagIA Diagnostics
About this trial
Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prospectively or retrospectively in Ivory Coast and Kenya.
Eligibility criteria
Qualifiers
Provide informed consent for participation in this study.
HIV-1 Ab positive
HIV-2 Ab positive
HCV-Ab positive
Disqualifiers
Samples from patients below 18 years of age
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
2Côte d’Ivoire
Centre de Diagnostic et de Recherche sur le SIDA et les autres Maladies Infectieuses - CHU Treichville Abidjan Côte d’Ivoire
Kenya
Kenya Medical Research Institute (KEMRI) Nairobi Kenya
Sponsors and collaborators
MagIA Diagnostics
Lead sponsor
Institut Pasteur
Collaborator
Kenya Medical Research Institute
Collaborator
Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire
Collaborator
Source ClinicalTrials.gov